Precigen's $13M Investor Settlement Gets Final Green Light
A California federal judge has granted final approval to a $13 million settlement between investors and biotechnology company Precigen Inc. over claims it misrepresented aspects of a program aimed at converting...To view the full article, register now.
Already a subscriber? Click here to view full article